Stocks · Health care · Biological Products, (No Diagnostic Substances)

Surrozen, Inc.

SRZN Clue Score17
United States Fiscal year ends December CIK 0001824893 Results filed 20 Oct 2026

What the insiders did No buying or selling

Insider
Date
Role
Action
Shares
Price
Amount
Tim Kutzkey
20 Oct 2026
Director
Exercised, kept indirect
517,241
$11.60
$6.00M
Tim Kutzkey
20 Oct 2026
Director
Exercised, kept indirect
548,653
$11.60
$6.36M
Tim Kutzkey
20 Oct 2026
Director
Exercised, kept indirect
485,830
$11.60
$5.64M
Column Group III Gp, LP
20 Oct 2026
10% owner
Exercised, kept indirect
517,241
$11.60
$6.00M
Column Group III Gp, LP
20 Oct 2026
10% owner
Exercised, kept indirect
548,653
$11.60
$6.36M
Column Group III Gp, LP
20 Oct 2026
10% owner
Exercised, kept indirect
485,830
$11.60
$5.64M

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 3,103,448
History held since 25 Nov 2020